Lucia Dansero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lucia Dansero has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
- Fulvio Ricceri
Centre for Biostatistics, Epidemiology, and Public Health, Department of Clinical and Biological Sciences, University of Turin, Orbassano, Turin, Italy
16 shared publications - Carlotta Sacerdote
Department of Health Sciences, University of Eastern Piedmont, Via Solaroli 17, 28100 Novara, Italy
13 shared publications - Alberto Catalano
Centre for Biostatistics, Epidemiology, and Public Health, Department of Clinical and Biological Sciences, University of Turin, Orbassano, Turin, Italy; Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy
10 shared publications - Roberto Gnavi
Epidemiology Unit, ASL TO3, Piedmont Region, Grugliasco, Italy
9 shared publications - Alex Bianchi
Centre for Biostatistics Epidemiology, and Public Health Department of Clinical and Biological Sciences University of Turin Orbassano Turin Italy unito.it
7 shared publications - Carmen Fava
Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
7 shared publications
Latest Publications
- Open Access
- 6 August 2026
- Published by Springer Nature in BMC Cancer
Body fatness, physical activity and the risk of cervical cancer: Results from the EPIC cohort
- 6 August 2026
- Published by Springer Nature in BMC Cancer
Open AccessBody fatness, physical activity and the risk of cervical cancer: Results from the EPIC cohort
- Open Access
- 23 June 2026
- Published by Elsevier in Social Science & Medicine
- Vol. 404, 119519
Syndemic interactions in northwest Italy: education, place of birth, and the co-occurrence of type 2 diabetes and depression
- 23 June 2026
- Published by Elsevier in Social Science & Medicine
- Vol. 404, 119519
Open AccessSyndemic interactions in northwest Italy: education, place of birth, and the co-occurrence of type 2 diabetes and depression
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Risk of Cardiovascular and Cerebrovascular Diseases in Patients with Myeloid Neoplasms: Results from 1.8 Million Inhabitants of Northwest Italy
Supplementary Table 4 shows the descriptive statistics related to subjects affected by Myelodysplastic Syndromes, stratified by the age groups investigated
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Risk of Cardiovascular and Cerebrovascular Diseases in Patients with Myeloid Neoplasms: Results from 1.8 Million Inhabitants of Northwest Italy
Supplementary Table 4 shows the descriptive statistics related to subjects affected by Myelodysplastic Syndromes, stratified by the age groups investigated
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Risk of Cardiovascular and Cerebrovascular Diseases in Patients with Myeloid Neoplasms: Results from 1.8 Million Inhabitants of Northwest Italy
Supplementary Table 5 shows the descriptive statistics related to subjects affected by Myeloproliferative Neoplasm, stratified by the age groups investigated
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Risk of Cardiovascular and Cerebrovascular Diseases in Patients with Myeloid Neoplasms: Results from 1.8 Million Inhabitants of Northwest Italy
Supplementary Table 5 shows the descriptive statistics related to subjects affected by Myeloproliferative Neoplasm, stratified by the age groups investigated
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Risk of Cardiovascular and Cerebrovascular Diseases in Patients with Myeloid Neoplasms: Results from 1.8 Million Inhabitants of Northwest Italy
Supplementary Table 2 shows the descriptive statistics related to subjects affected by Chronic Myeloid Leukemia, stratified by the age groups investigated
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Risk of Cardiovascular and Cerebrovascular Diseases in Patients with Myeloid Neoplasms: Results from 1.8 Million Inhabitants of Northwest Italy
Supplementary Table 2 shows the descriptive statistics related to subjects affected by Chronic Myeloid Leukemia, stratified by the age groups investigated
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Data from Risk of Cardiovascular and Cerebrovascular Diseases in Patients with Myeloid Neoplasms: Results from 1.8 Million Inhabitants of Northwest Italy
Background:Myeloid neoplasms are a group of pathologies characterized by clonal hematopoiesis and genetic mutations, often associated with inflammation and cardiovascular (CV) risk. Whereas targeted therapies have improved prognosis, they may also lead to CV adverse effects. The aim was to analyze the risk of developing CV or cerebrovascular disease (CVD) events in patients who received a diagnosis of myeloid neoplasm, considering four subgroups of myeloid neoplasms: chronic myeloid leukemia, myeloproliferative neoplasm, myelodysplastic syndromes (MDS), and acute myeloid leukemia.Methods:Data were obtained from the Piedmont Longitudinal Study, including all subjects present in the census conducted in October 2011 and who were 40 to 80 years old. The association between myeloid neoplasms and CV and/or cerebrovascular diseases was evaluated through competing risks analyses, both on the entire sample and considering 40- to 64- and 65- to 80-year-old subgroups.Results:Of 1,795,216 subjects, 1,395 received a diagnosis of myeloid neoplasm and 82,978 experienced CVDs. Patients with myeloid neoplasms exhibited different CVD risks. In the younger population, CLM resulted associated with cerebrovascular events and MDS with myocardial infarction. In the older patients, chronic myeloid leukemia was associated with heart failure, acute myeloid leukemia with CVD events, MDS with CV, particularly heart failure and peripheral vascular disease, and cerebrovascular events, and myeloproliferative neoplasm with CV events, especially peripheral vascular disease.Conclusions:The results highlighted the importance of implementing a specific CVD prevention and surveillance plan for patients with myeloid neoplasms.Impact:Study evidence underlines which myeloid neoplasm patient subgroups require increased attention and monitoring to prevent future CVD events.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Risk of Cardiovascular and Cerebrovascular Diseases in Patients with Myeloid Neoplasms: Results from 1.8 Million Inhabitants of Northwest Italy
Background:Myeloid neoplasms are a group of pathologies characterized by clonal hematopoiesis and genetic mutations, often associated with inflammation and cardiovascular (CV) risk. Whereas targeted therapies have improved prognosis, they may also lead to CV adverse effects. The aim was to analyze the risk of developing CV or cerebrovascular disease (CVD) events in patients who received a diagnosis of myeloid neoplasm, considering four subgroups of myeloid neoplasms: chronic myeloid leukemia, myeloproliferative neoplasm, myelodysplastic syndromes (MDS), and acute myeloid leukemia.Methods:Data were obtained from the Piedmont Longitudinal Study, including all subjects present in the census conducted in October 2011 and who were 40 to 80 years old. The association between myeloid neoplasms and CV and/or cerebrovascular diseases was evaluated through competing risks analyses, both on the entire sample and considering 40- to 64- and 65- to 80-year-old subgroups.Results:Of 1,795,216 subjects, 1,395 received a diagnosis of myeloid neoplasm and 82,978 experienced CVDs. Patients with myeloid neoplasms exhibited different CVD risks. In the younger population, CLM resulted associated with cerebrovascular events and MDS with myocardial infarction. In the older patients, chronic myeloid leukemia was associated with heart failure, acute myeloid leukemia with CVD events, MDS with CV, particularly heart failure and peripheral vascular disease, and cerebrovascular events, and myeloproliferative neoplasm with CV events, especially peripheral vascular disease.Conclusions:The results highlighted the importance of implementing a specific CVD prevention and surveillance plan for patients with myeloid neoplasms.Impact:Study evidence underlines which myeloid neoplasm patient subgroups require increased attention and monitoring to prevent future CVD events.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Risk of Cardiovascular and Cerebrovascular Diseases in Patients with Myeloid Neoplasms: Results from 1.8 Million Inhabitants of Northwest Italy
Supplementary Table 3 shows the descriptive statistics related to subjects affected by Acute Myeloid Leukemia, stratified by the age groups investigated
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Risk of Cardiovascular and Cerebrovascular Diseases in Patients with Myeloid Neoplasms: Results from 1.8 Million Inhabitants of Northwest Italy
Supplementary Table 3 shows the descriptive statistics related to subjects affected by Acute Myeloid Leukemia, stratified by the age groups investigated
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Risk of Cardiovascular and Cerebrovascular Diseases in Patients with Myeloid Neoplasms: Results from 1.8 Million Inhabitants of Northwest Italy
Supplementary Table 1 shows the algorithms used to identify outcomes, exposures, and clinical and pharmaceutical confounders
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Risk of Cardiovascular and Cerebrovascular Diseases in Patients with Myeloid Neoplasms: Results from 1.8 Million Inhabitants of Northwest Italy
Supplementary Table 1 shows the algorithms used to identify outcomes, exposures, and clinical and pharmaceutical confounders
- Open Access
- 1 December 2025
- Published by Wiley in Liver International
- Vol. 46 (1) , e70458
Exploring the Syndemic of Steatotic Liver Disease, Socioeconomic Inequities and Cancer Risk in the UK Biobank
Background: Steatotic liver disease (SLD), formerly known as fatty liver disease, is associated with increased cancer risk. However, the impact of socioeconomic inequities remains understudied. This study investigates the relationship between SLD, socioeconomic position (SEP) and cancer risk using a syndemic framework. Methods: Using UK Biobank data, we defined metabolic dysfunction‐associated SLD (MASLD), MASLD with increased alcohol intake (MetALD) and alcoholic liver disease (ALD), based on the Fatty Liver Index, cardiometabolic criteria and alcohol consumption. SEP was derived via latent class analysis using education, household income and employment. We used Cox proportional hazards models to examine the associations between MASLD, MetALD and ALD and the incidence of any, obesity‐related and digestive cancers. We then evaluated the combined effect of these SLD subcategories and SEP on cancer outcomes. Results: Among 325 476 individuals, 91 651 had MASLD, 25 649 MetALD and 8005 ALD. Over 11.7 years median follow‐up, 35 775 first incident cancers occurred (15 426 obesity‐related; 6959 digestive). MASLD, MetALD and ALD were each associated with an increased risk of all cancer outcomes (hazard ratios [HR] ranging from 1.09 to 1.73). The combination of MASLD and low SEP was associated with an increased risk of any (HR: 1.14, 95% CI: 1.08–1.19), obesity‐related (HR: 1.25, 95% CI: 1.16–1.33) and digestive cancers (HR: 1.37, 95% CI: 1.23–1.53). Similar trends were observed for individuals with MetALD or ALD and low SEP across all cancer outcomes. Conclusion: SLD is independently associated with increased risk of any, obesity‐related and digestive cancers. These risks are amplified by socioeconomic inequities, highlighting the need for integrated approaches that consider both clinical and social determinants of health.
- 1 December 2025
- Published by Wiley in Liver International
- Vol. 46 (1) , e70458
Open AccessExploring the Syndemic of Steatotic Liver Disease, Socioeconomic Inequities and Cancer Risk in the UK Biobank
Background: Steatotic liver disease (SLD), formerly known as fatty liver disease, is associated with increased cancer risk. However, the impact of socioeconomic inequities remains understudied. This study investigates the relationship between SLD, socioeconomic position (SEP) and cancer risk using a syndemic framework. Methods: Using UK Biobank data, we defined metabolic dysfunction‐associated SLD (MASLD), MASLD with increased alcohol intake (MetALD) and alcoholic liver disease (ALD), based on the Fatty Liver Index, cardiometabolic criteria and alcohol consumption. SEP was derived via latent class analysis using education, household income and employment. We used Cox proportional hazards models to examine the associations between MASLD, MetALD and ALD and the incidence of any, obesity‐related and digestive cancers. We then evaluated the combined effect of these SLD subcategories and SEP on cancer outcomes. Results: Among 325 476 individuals, 91 651 had MASLD, 25 649 MetALD and 8005 ALD. Over 11.7 years median follow‐up, 35 775 first incident cancers occurred (15 426 obesity‐related; 6959 digestive). MASLD, MetALD and ALD were each associated with an increased risk of all cancer outcomes (hazard ratios [HR] ranging from 1.09 to 1.73). The combination of MASLD and low SEP was associated with an increased risk of any (HR: 1.14, 95% CI: 1.08–1.19), obesity‐related (HR: 1.25, 95% CI: 1.16–1.33) and digestive cancers (HR: 1.37, 95% CI: 1.23–1.53). Similar trends were observed for individuals with MetALD or ALD and low SEP across all cancer outcomes. Conclusion: SLD is independently associated with increased risk of any, obesity‐related and digestive cancers. These risks are amplified by socioeconomic inequities, highlighting the need for integrated approaches that consider both clinical and social determinants of health.
- Open Access
- 21 October 2025
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 14 (1) , 1-12
Safe and respectful? Birth attendants’ hand hygiene compliance and its determinants using nationally representative data from Kenya, Malawi and Nepal
Background: In low and middle-income countries (LMICs), infections acquired during childbirth contribute significantly to maternal and neonatal mortality. Hand hygiene (HH) is critical in preventing the spread of infections, yet compliance remains inadequate. This study investigates birth attendants’ HH compliance during labour, delivery, and postpartum in LMICs, using nationally representative data from Service Provision Assessments (SPAs) in Kenya, Malawi, and Nepal. Methods: We analysed 1565 observed deliveries across 517 health facilities, resulting in 3919 HH opportunities. The outcomes were hand washing or hand disinfectant use: (1) before any initial examination, (2) before aseptic procedures during labour, (3) after birth. We used descriptive statistics to assess HH compliance and multivariate multilevel mixed-effect logistic regressions to investigate determinants, accounting for facility and individual clustering. Findings: Hand hygiene compliance varied significantly across countries, with Kenya showing the lowest rates, while Malawi and Nepal had higher compliance levels. Supportive and effective communication towards pregnant women was significantly associated with an increase in HH compliance before the vaginal examination (Kenya - OR: 5.94, 95% CI 1.68-21.0; Malawi - OR: 2.19, 95% CI 1.04–4.65) and before aseptic procedures (Kenya - OR: 4.03, 95% CI 1.81–8.96; Malawi - OR: 4.01, 95% CI 1.69–9.50; Nepal - OR: 2.66, 95% CI 1.30–5.44). HH compliance during aseptic procedures during labour was also associated with recent IPC training in Malawi (OR: 3.48,95%CI 1.44–8.41) and facility infrastructure (OR: 6.14,95%CI 1.07–35.3). Conclusion: Low hand hygiene compliance during birth, especially before aseptic procedures, can lead to healthcare-associated infections with serious consequences for mothers and newborns. Future research should investigate further the association between effective communication and hand hygiene.
- 21 October 2025
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 14 (1) , 1-12
Open AccessSafe and respectful? Birth attendants’ hand hygiene compliance and its determinants using nationally representative data from Kenya, Malawi and Nepal
Background: In low and middle-income countries (LMICs), infections acquired during childbirth contribute significantly to maternal and neonatal mortality. Hand hygiene (HH) is critical in preventing the spread of infections, yet compliance remains inadequate. This study investigates birth attendants’ HH compliance during labour, delivery, and postpartum in LMICs, using nationally representative data from Service Provision Assessments (SPAs) in Kenya, Malawi, and Nepal. Methods: We analysed 1565 observed deliveries across 517 health facilities, resulting in 3919 HH opportunities. The outcomes were hand washing or hand disinfectant use: (1) before any initial examination, (2) before aseptic procedures during labour, (3) after birth. We used descriptive statistics to assess HH compliance and multivariate multilevel mixed-effect logistic regressions to investigate determinants, accounting for facility and individual clustering. Findings: Hand hygiene compliance varied significantly across countries, with Kenya showing the lowest rates, while Malawi and Nepal had higher compliance levels. Supportive and effective communication towards pregnant women was significantly associated with an increase in HH compliance before the vaginal examination (Kenya - OR: 5.94, 95% CI 1.68-21.0; Malawi - OR: 2.19, 95% CI 1.04–4.65) and before aseptic procedures (Kenya - OR: 4.03, 95% CI 1.81–8.96; Malawi - OR: 4.01, 95% CI 1.69–9.50; Nepal - OR: 2.66, 95% CI 1.30–5.44). HH compliance during aseptic procedures during labour was also associated with recent IPC training in Malawi (OR: 3.48,95%CI 1.44–8.41) and facility infrastructure (OR: 6.14,95%CI 1.07–35.3). Conclusion: Low hand hygiene compliance during birth, especially before aseptic procedures, can lead to healthcare-associated infections with serious consequences for mothers and newborns. Future research should investigate further the association between effective communication and hand hygiene.